桂林莱茵生物科技股份有限公司大股东部分股份解除质押公告解读

主要内容概述

2026年4月20日，桂林莱茵生物科技股份有限公司（证券代码：002166，简称“莱茵生物”）发布公告，披露公司大股东秦本军先生已解除部分股份质押。此次解押事项对于投资者具有一定关注价值，尤其是对公司股权结构和潜在市场风险的影响。

公告关键点梳理

• 解押股份数量：秦本军先生本次解除了2,640万股公司股份的质押，占其所持公司股份的9.73%，占公司总股本的3.56%。
• 质押起止时间：本次质押自2022年7月28日开始，2026年4月16日解除，质权人为国海证券股份有限公司。
• 解除质押原因：秦本军先生已向国海证券偿还全部融资借款，完成相关解除质押手续。

股东股份累计质押情况

• 秦本军先生持股情况：截至公告披露日，秦本军先生持有公司股份27,138.96万股，占公司总股本的36.59%。
• 累计已质押股份：7,830万股，占其所持股份的28.85%，占公司总股本的10.56%。
• 质押风险：公告明确表示，秦本军先生资信状况良好，具备履约能力，目前所质押股份不存在平仓风险或被强制平仓的情形。

对投资者的影响与风险提示

• 本次解除质押，表明大股东的财务压力有所缓解，有助于提升市场信心，降低公司股权结构的不确定性。
• 公告重申，剩余质押股份没有平仓风险，对公司生产经营和公司治理无不利影响。
• 未来如有股份质押或解押事项，公司将依法及时披露，投资者需持续关注潜在变化。

投资者需关注的重点

• 大股东股份质押比例变化，可能影响公司股权结构稳定性和市场对公司风险的评估。
• 大股东解押部分股份后，整体质押比例依然不低（占其持股约28.85%），后续如遇市场波动，仍需警惕潜在风险。
• 本次公告属于公司大股东资金状况及股份质押变动的重大信息，具有潜在影响公司股价的可能，建议投资者密切关注。

备查文件

• 中国证券登记结算有限责任公司证券质押及司法冻结明细表
• 股份解除质押证明文件

免责声明：本文内容仅供投资者参考，不构成任何投资建议。投资者应结合自身实际情况，审慎决策。公司未来股价受多重因素影响，历史信息不代表未来表现。

English Version

Analysis of Share Pledge Release by Major Shareholder of Guilin Layn Natural Ingredients Corp.

Summary of Key Announcement

On April 20, 2026, Guilin Layn Natural Ingredients Corp. (Stock code: 002166, “Layn Bio”) disclosed that major shareholder Mr. Qin Benjun has released part of his pledged shares. This development is noteworthy for investors given its implications on shareholding structure and market risk.

Key Points from the Announcement

• Number of Shares Released: Mr. Qin released the pledge on 26.4 million shares, which is 9.73% of his holdings and 3.56% of the company’s total shares.
• Pledge Period: The shares were pledged from July 28, 2022, and released on April 16, 2026. The pledgee was Guohai Securities Co., Ltd.
• Reason for Release: Mr. Qin has repaid all related financing loans to Guohai Securities, leading to the release of the pledged shares.

Cumulative Share Pledge Details

• Current Shareholding: Mr. Qin holds 271.3896 million shares, making up 36.59% of the company’s total shares.
• Total Pledged Shares: 78.3 million shares remain pledged, accounting for 28.85% of his holdings and 10.56% of the company’s total shares.
• Pledge Risk: The company states that Mr. Qin’s credit and contract performance capabilities are sound and there is currently no risk of forced sale or margin call on the pledged shares.

Implications and Risk Reminders for Investors

• The release of pledged shares signals an improvement in the major shareholder’s financial status and reduces uncertainty in the company’s shareholding structure, potentially boosting market confidence.
• The remaining pledged shares do not currently pose forced sale risks, thus not adversely affecting company operations or governance.
• Future changes in share pledges or releases will be disclosed in a timely manner as per regulations. Investors are advised to monitor related developments closely.

Key Points Investors Should Note

• Changes in the major shareholder’s pledge ratio can impact the stability of the company’s shareholding structure and market risk assessment.
• After this release, the overall pledge ratio remains relatively high (about 28.85% of his holdings). Further market volatility could still pose risks.
• This announcement is significant regarding the major shareholder’s financial and pledge status, and could potentially move the share price. Investors should pay close attention.

Reference Documents

• CSRC Pledge and Judicial Freezing Details Table
• Share Pledge Release Certificate

Disclaimer: The content above is for investors’ reference only and does not constitute investment advice. Investors should make prudent decisions based on their own circumstances. Past information does not guarantee future performance.

View 莱茵生物 Historical chart here